دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
A prospective evaluation of a redefined version of the “minimalistic hybrid approach” algorithm for percutaneous coronary chronic total occlusion revascularization
Pierfrancesco Agostoni MD, PhD,Benjamin Scott MD,Simone Budassi MD,Stefan Verheye MD, PhD,Carl Convens MD,Paul Vermeersch MD, PhD,Carlo Zivelonghi MD
doi : 10.1002/ccd.29158
Volume 98, Issue 4 p. 617-625
Aim of this study is to prospectively assess the feasibility of the “Minimalistic Hybrid Approach” (MHA) algorithm for chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
Intermediate procedural and health status outcomes and the clinical care pathways after chronic total occlusion angioplasty: A report from the OPEN-CTO (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures) study
James Sapontis MBBCh,Taishi Hirai MD,Christian Patterson MS,Benjamin Gans BS,Robert W. Yeh MD, MSc,William Lombardi MD,Dimitri Karmpaliotis MD,Jeffrey Moses MD,William J. Nicholson MD,Ashish Pershad MD,R. Michael Wyman MD,Anthony Spaedy MD,Stephen Cook MD,Parag Doshi MD,Robert Federici MD,Craig A. Thompson MD,Karen Nugent RRT,Kensey Gosch MS,J. Aaron Grantham MD,Adam C. Salisbury MD, MSc
doi : 10.1002/ccd.29343
Volume 98, Issue 4 p. 626-635
No previous reports have described the comprehensive care pathways involved in chronic total occlusion percutaneous coronary intervention (CTO PCI).
Why observational studies are key? Health status outcomes and clinical care pathways
Jorge Belardi MD FSCAI FACC,Pablo Lamelas MD MSc
doi : 10.1002/ccd.29910
Volume 98, Issue 4 p. 636-637
ST-elevation myocardial infarction in nonagenarians: A nationwide analysis of trends and outcomes in the United States
Venkata S. Pajjuru MD,Abhishek Thandra MD,Raviteja R. Guddeti MD,Srikanth R. Kothapalli MD,Ryan W. Walters PhD,Aravdeep Jhand MD,Ahmed Aboeata MD,Venkata G. Andukuri MD, MPH,Andrew M. Goldsweig MD, MS
doi : 10.1002/ccd.29313
Volume 98, Issue 4 p. 638-646
To assess ST elevation myocardial infarction (STEMI) trends and outcomes in nonagenarians undergoing primary percutaneous coronary intervention (pPCI) compared to medical management.
STEMI in 90-year-olds: The good news and the bad news!
Rebekah Lantz DO,Timothy D. Henry MD
doi : 10.1002/ccd.29899
Volume 98, Issue 4 p. 647-648
Iatrogenic catheter-induced ostial coronary artery dissections: Prevalence, management, and mortality from a cohort of 55,968 patients over 10?years
Anantharaman Ramasamy MBChB, MRCP,Retesh Bajaj MBBS, MRCP,Daniel A Jones MBBS, PhD,Rajiv Amersey MD,Anthony Mathur MD, PhD,Andreas Baumbach MD,Christos V. Bourantas MD, PhD,Constantinos O'Mahony MD(Res), FRCP(UK)
doi : 10.1002/ccd.29382
Volume 98, Issue 4 p. 649-655
We sought to describe the prevalence, management strategies and evaluate the prognosis of patients with iatrogenic catheter-induced ostial coronary artery dissection (ICOCAD).
The disasters we create: Iatrogenic catheter-induced ostial coronary artery dissection
David Sosa IV MD,James C. Blankenship MD MHCM, MSCAI
doi : 10.1002/ccd.29904
Volume 98, Issue 4 p. 656-657
Side branch fractional flow reserve after provisional stenting of calcified bifurcation lesions: The ORBID-FFR study
Annapoorna S. Kini MD,Naotaka Okamoto MD,Nitin Barman MD,Yuliya Vengrenyuk PhD,Keisuke Yasumura MD,Surbhi Chamaria MD,Samit Bhatheja MD, MPH,Vishal Kapur MD,Choudhury Hasan MD,Joseph Sweeny MD,Usman Baber MD,Roxana Mehran MD,Gregg W. Stone MD,Samin Sharma MD
doi : 10.1002/ccd.29307
Volume 98, Issue 4 p. 658-668
We examined the incidence of side branch (SB) compromise after provisional stenting of calcified bifurcation lesions treated with rotational atherectomy (RA) or cutting balloon angioplasty (CBA) and the utility of optical coherence tomography (OCT) to detect functionally significant SB stenoses.
Does rotoblation or cutting balloon before provisional stenting of calcified side branches make any difference? Comparing results by OCT and FFR
Morton J. Kern MD, MSCAI, FAHA
doi : 10.1002/ccd.29907
Volume 98, Issue 4 p. 669-670
Validation of novel 3-dimensional quantitative coronary angiography based software to calculate fractional flow reserve post stenting
Kaneshka Masdjedi MD,Laurens JC van Zandvoort BSc,Matthew M Balbi MD,Rutger-Jan Nuis MD, PhD,Jeroen Wilschut MD,Roberto Diletti MD, PhD,Peter P.T. de Jaegere MD, PhD … See all authors
doi : 10.1002/ccd.29311
Volume 98, Issue 4 p. 671-677
To validate novel dedicated 3D-QCA based on the software to calculate post PCI vessel-FFR (vFFR) in a consecutive series of patients, to assess the diagnostic accuracy, and to assess inter-observer variability.
Rotational atherectomy and same day discharge: Safety and growth from a national perspective
Paraskevi Taxiarchi PhD,Glen P. Martin PhD,Nick Curzen BM, PhD,Tim Kinnaird MD,Peter Ludman MD,Thomas Johnson MD,Chun Shing Kwok MBBS, BSc, MSc, PhD,Muhammad Rashid PhD,Evangelos Kontopantelis PhD,Mamas A. Mamas BM BCh, MA, DPhil
doi : 10.1002/ccd.29228
Volume 98, Issue 4 p. 678-688
We explore whether same day discharge (SDD) is a feasible and safe practice following rotational atherectomy (ROTA) treatment during elective percutaneous coronary intervention (PCI), and examine which baseline characteristics are independently associated with SDD.
Finding sideline benefits—Of pandemics and same-day-discharge following rotational atherectomy
Hussam Hawamdeh MD,David J. Moliterno MD
doi : 10.1002/ccd.29909
Volume 98, Issue 4 p. 689-690
Clinical relevance of adding intravascular ultrasound to coronary angiography for the diagnosis of extrinsic left main coronary artery compression by a pulmonary artery aneurysm in pulmonary hypertension
Maite Velázquez Martín MD,José M Montero Cabezas MD,Sergio Huertas MD,Jorge Nuche MD,Agustín Albarrán MD, PhD,Juan F Delgado MD, PhD,Sergio Alonso MD, PhD,Fernando Sarnago MD,Fernando Arribas MD, PhD,Pilar Escribano Subias MD, PhD
doi : 10.1002/ccd.29194
Volume 98, Issue 4 p. 691-700
We sought to assess the clinical value of adding intravascular ultrasound (IVUS) evaluation to coronary angiography (CA) to guide extrinsic left main coronary artery (LMCA) compression diagnosis and treatment in pulmonary hypertension (PH).
Seeing is believing: The use of intravascular ultrasound to diagnose left main coronary artery compression
Nachiket J. Patel MD,Richard R. Heuser MD
doi : 10.1002/ccd.29902
Volume 98, Issue 4 p. 701-702
Cost savings for pVAD compared to ECMO in the management of acute myocardial infarction complicated by cardiogenic shock: An episode-of-care analysis
George W. Vetrovec MD,Michael J. Lim MD,Keith A. Needham BS
doi : 10.1002/ccd.29181
Volume 98, Issue 4 p. 703-710
Acute myocardial infarction complicated by cardiogenic shock (AMICS) occurs in up to 10% of acute myocardial infarction admissions and is associated with high mortality, frequent adverse outcomes, prolonged hospitalizations, extensive medical resource utilization, and major cost. Using hospital cost data for Medicare Fee-for-Service (FFS) patients with AMICS, we sought to evaluate in hospital and 45-day outcomes and cost, comparing patients treated with percutaneous ventricular assist device (pVAD) versus extracorporeal membrane oxygenation (ECMO). The goal of this study was to better understand clinical and economic outcomes of AMICS to help clinicians and hospitals optimize outcomes most economically for AMICS patients.
Making sense of the costs of life and death interventions
Amit P. Amin MD, MSc, MBA, FSCAI,Arnold H. Seto MD, MPA, FSCAI
doi : 10.1002/ccd.29905
Volume 98, Issue 4 p. 711-712
Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub-study
Laura S.M. Kerkmeijer MD,Ruben Y.G. Tijssen MD,Sjoerd H. Hofma MD, PhD,Rene J. van der Schaaf MD, PhD,E. Karin Arkenbout MD, PhD,Auke P.J.D. Weevers MD,Robin P. Kraak MD,Yoshinobu Onuma MD, PhD,Patrick W. Serruys MD, PhD,Jan J. Piek MD, PhD,Jan G.P. Tijssen PhD,Jose P.S. Henriques MD, PhD,Robbert J. de Winter MD, PhD,Joanna J. Wykrzykowska MD, PhD
doi : 10.1002/ccd.29329
Volume 98, Issue 4 p. 713-720
In this prespecified AIDA-trial sub-study we investigate the clinical performance of absorb bioresorbable vascular scaffold (BVS) compared to Xience everolimus-eluting stent (EES) in routine percutaneous coronary intervention (PCI) in patients with diabetes mellitus (DM) at complete 3-year follow-up.
Diabetes and everolimus eluting bioresorbable poly-L-lactide vascular scaffolds for coronary artery disease: Dead-end or some path forward?
William B. Hillegass MD, PhD
doi : 10.1002/ccd.29900
Volume 98, Issue 4 p. 721-722
Very late vasomotor responses and gene expression with bioresorbable scaffolds and metallic drug-eluting stents
Jin-Sin Koh MD,Bill D. Gogas MD,Sandeep Kumar PhD,James J. Benham BS,Sanjoli Sur BS,Nikolaos Spilias MD,Arnav Kumar MD,Don P. Giddens PhD,Richard Rapoza PhD,Dean J. Kereiakes MD,Gregg Stone MD,Hanjoong Jo PhD,Habib Samady MD
doi : 10.1002/ccd.29819
Volume 98, Issue 4 p. 723-732
To investigate the long-term vasomotor response and inflammatory changes in Absorb bioresorbable vascular scaffold (BVS) and metallic drug-eluting stent (DES) implanted artery.
Percutaneous closure of a patent foramen ovale causing exercise hypoxemia: Case report and a review of the literature
Georg Punzengruber MD,Rainer Kolb MD,Bernhard Meier MD,Ronald K. Binder MD
doi : 10.1002/ccd.29825
Volume 98, Issue 4 p. 733-737
Provoked exercise desaturation is a rare presentation of patent foramen ovale (PFO), when vigorous exercise leads to desaturation of arterial blood and subsequent dyspnea. We present a case of provoked exercise desaturation and curative percutaneous closure and review the literature. A 54-year-old male patient presented with shortness of breath during exercise in the pneumology outpatient department. During exercise spirometry, a relevant drop in arterial oxygen saturation and partial pressure of oxygen was observed and a right-left shunt suspected. In a transesophageal echocardiogram, a PFO was observed. Cardiac catheterization documented a right-left-shunt causing desaturation during exercise. Following percutaneous closure of the PFO, exercise induced desaturation was no longer detectable during exercise spirometry and there was considerable improvement in exercise capacity and subjective dyspnea. To sum up, provoked exercise desaturation is a rare but curable presentation of PFO. Percutaneous closure is a safe and effective way to treat this entity.
Role of tenecteplase (rtPA) to re-establish flow in intraprocedural stent thrombosis in infants undergoing ductal stenting for duct-dependent pulmonary circulation—a case series
Jason Weng Yew Tan MBBS, MRCPCH,Mazeni Alwi MBBS, MRCP,Esther Lee Ling Siew BPharm,Hasri Samion MD, MMed
doi : 10.1002/ccd.29838
Volume 98, Issue 4 p. 738-742
Ductal stenting in patients with duct-dependent pulmonary circulation has allowed growth of pulmonary arteries prior to definitive surgical procedures. Intraprocedural stent thrombosis (IPST) of the arterial duct is a life-threatening complication as it leads to total circulatory collapse. Previous reports have described use of tissue plasminogen activators in infants for less emergent settings. We report three infants with IPST and the use of tenecteplase to overcome this. Also discussed are the predisposing mechanisms in each scenario and a possibility of direct catheter-guided tenecteplase administration. Judicious use of tenecteplase can be life-saving and rapid access to this drug may obviate the need for emergency extracorporeal life support.
Antegrade and retrograde in-stent tibial artery chronic total occlusion recanalization with double kiss crush (DK crush) stenting of previous stent
Sehrish Memon MD,Jon C. George MD,Sanjog Kalra MD,Sean Janzer MD
doi : 10.1002/ccd.29516
Volume 98, Issue 4 p. 743-747
Below the knee (BTK) peripheral arterial disease often presents with critical limb ischemia (CLI) clinically with involvement of more than one tibial vessels. Drug eluting stent (DES) technology for treatment of BTK disease has shown promising long-term durable results; however, currently only coronary DESs are available for application in the United States. Although coronary bifurcation stenting techniques are backed by extensive data in literature, there is a scarcity of data for the treatment of tibial bifurcation disease. Bifurcation angles in the tibials are similar to those in the coronaries and therefore the same two stent bifurcation technique can be applied in BTK disease. Double Kiss crush (DK crush) stenting has superior outcomes when compared to provisional or culotte stenting in randomized coronary trials (based on Medina classification). We present a case of BTK CLI with tibial bifurcation chronic total occlusion treated with two stent DK crush technique using coronary DES.
Endovascular management of the deep venous thrombosis: A new challenging role for the endovascular specialist in 2020
Marco Midulla MD PhD,Olivier Chevallier MD,Pierre-Olivier Comby MD,Giuseppe Giordano MD,Lorenzo Carlo Pescatori MD,Nicolas Falvo MD,Jos C3 van den Berg MD PhD,Maurizio Cariati MD,Romaric Loffroy MD PhD
doi : 10.1002/ccd.29375
Volume 98, Issue 4 p. 748-755
Over the last years, the endovascular approach to the management of the acute and chronic deep vein thrombosis (DVT) has gained more and more attention from the scientific community. DVT is the third most common cardiovascular disease after coronary heart disease and stroke, with classic treatment based on anticoagulation. Recent evidences have highlighted the risk of postthrombotic syndrome as high as 30%–50% in proximal ilio-femoral lesions, with irreversible clinical symptoms and impact on the quality of life of the population. Since 2000s, the new concept of thrombus removal in the acute phase has been supported by the introduction of different techniques based on the endovascular ablation of the clot by in-situ fibrinolysis and, more recently, fragmentation and aspiration. In the chronic phase, recanalization of the thrombosed segment is recommended by stent placement to remove the obstruction and eventually reduce the congestion. Immediate technical success of these procedures is widely satisfying, whereas the long-term clinical benefits are still debated. This paper presents an overview of the modern management of the DVT by endovascular approach with regard to the clinical contexts, interventional strategies and clinical outcomes. Endovascular specialist needs to be aware of this incoming challenge, as local expertise is demanded for the modern management of these patients in multidisciplinary theaters.
Bioprosthetic valve fracture: Predictors of outcome and follow-up. Results from a multicenter study
Christina Brinkmann MD,Mohamed Abdel-Wahab MD,Francesco Bedogni MD,Oliver D. Bhadra MD,Gaetan Charbonnier MD,Lenard Conradi MD, PhD,David Hildick-Smith MD, PhD,Faraj Kargoli MD, MPH,Azeem Latib MD, PhD,Nicolas M. Van Mieghem MD, PhD,Mizuki Miura MD,Darren Mylotte MD,Uri Landes MD,Thomas Pilgrim MD,Friedrich-Christian Riess MD, PhD,Maurizio Taramasso MD,Didier Tchétché MD,Luca Testa MD, PhD,Holger Thiele MD, PhD,John Webb MD, PhD,Stephan Windecker MD,Julian Witt MD,Peter Wohlmuth PhD,Alexander Wolf MD,Joachim Schofer MD, PhD
doi : 10.1002/ccd.29755
Volume 98, Issue 4 p. 756-764
To evaluate outcome and its predictors of bioprosthetic valve fracture (BVF) in patients undergoing valve-in-valve transcatheter aortic valve replacement (VIV-TAVR).
Bioprosthetic valve fracture for aortic valve-in-valve procedures: Handle with care-extra weapon
Giuseppe Tarantini MD, PhD,Andrea Scotti MD
doi : 10.1002/ccd.29908
Volume 98, Issue 4 p. 765-766
A meta-analysis of transcarotid versus transfemoral transcatheter aortic valve replacement
Daniel P. McGrath BS,Masashi Kawabori MD,Benjamin Wessler MD,Frederick Y. Chen MD, PhD,Yong Zhan MD
doi : 10.1002/ccd.29768
Volume 98, Issue 4 p. 767-773
Carotid access has shown promise as an excellent delivery route for transcatheter aortic valve replacement (TAVR). We aimed to compare outcomes of transcarotid (TC) and transfemoral (TF) TAVR by conducting a search and analysis of the best evidence in the literature to shed light on its safety and effectiveness.
Transcarotid access as a first alternative approach to transcatheter aortic valve replacement
Giuseppe Musumeci MD,Gianmarco Annibali MD
doi : 10.1002/ccd.29906
Volume 98, Issue 4 p. 774-775
Hemolysis after transcatheter mitral valve replacement in degenerated bioprostheses, annuloplasty rings, and mitral annular calcification: Incidence, patient characteristics, and clinical outcomes
Bassim El-Sabawi MD,Mayra E. Guerrero MD,Mackram F. Eleid MD,Vuyisile T. Nkomo MD, MPH,Sorin V. Pislaru MD, PhD,Charanjit S. Rihal MD
doi : 10.1002/ccd.29779
Volume 98, Issue 4 p. 776-785
To determine the incidence, characteristics, and outcomes of patients with hemolysis after transcatheter mitral valve replacement (TMVR).
Hemolysis after transcatheter mitral valve replacement: An underreported phenomenon!
Yoshiyuki Okuya MD,Issam D. Moussa MD, MBA
doi : 10.1002/ccd.29901
Volume 98, Issue 4 p. 786-787
Left atrial appendage closure for stroke prevention in atrial fibrillation: Final report from the French left atrial appendage closure registry
Emmanuel Teiger MD, PhD,Jean-Benoit Thambo MD, PhD,Pascal Defaye MD,Jean-Sylvain Hermida MD,Sélim Abbey MD,Didier Klug MD, PhD,Jean-Michel Juliard MD,Christian Spaulding MD, PhD,Sébastien Armero MD,Didier Champagnac MD,Hamza Bhugaloo MS,Julien Ternacle MD, PhD,Nicolas Lellouche MD, PhD,Etienne Audureau MD, PhD,Philippe Le Corvoisier MD, PhD,the French national Left Atrial Appendage Closure registry (FLAAC) investigators
doi : 10.1002/ccd.29795
Volume 98, Issue 4 p. 788-799
The French left atrial appendage (LAA) closure registry (FLAAC) aimed to assess the safety and efficacy of LAA closure in daily practice.
Efficacy and safety of percutaneous patent foramen ovale closure in patients with a hypercoagulable disorder
Eyal Ben-Assa BSc, MD,Jesús Herrero-Garibi MD,Ignacio Cruz-Gonzalez MD,Sammy Elmariah MD, MPH,Pablo Rengifo-Moreno MD,Rasha Al-Bawardy MSc, MD,Rahul Sakhuja MSc, MPP, MD,Fabio V. Lima MD, MPH,Zareh N. Demirjian MD,Mingming Ning MMSc, MD,Ferdinando S. Buonanno MD,Ignacio Inglessis MD,Igor F. Palacios MD
doi : 10.1002/ccd.29835
Volume 98, Issue 4 p. 800-807
Transcatheter closure of patent foramen ovale (PFO) in patients with cryptogenic stroke reduces the rate of recurrent events. Although presence of thrombophilia increases the risk for paradoxical emboli through a PFO, such patients were excluded from large randomized trials.
Patent foramen ovale closure in patients with a hypercoagulable state—does it make a difference?
Alexander Postalian MD,Zvonimir Krajcer MD
doi : 10.1002/ccd.29903
Volume 98, Issue 4 p. 808-809
Successful radiofrequency perforation and balloon decompression of cor triatriatum sinister using novel technique, a case series
Benjamin A. Blais MD,Jamil A. Aboulhosn MD,Morris M. Salem MD,Daniel S. Levi MD
doi : 10.1002/ccd.29686
Volume 98, Issue 4 p. 810-814
Cor triatriatum sinister (CTS) is a rare congenital cardiac anomaly representing <0.1% of all congenital cardiac malformations. It is characterized by the presence of a left atrial (LA) membrane that leads to left ventricular inflow obstruction. Uncorrected, obstructed CTS may have significant sequelae such as pulmonary hypertension or arrhythmias. Transcatheter balloon decompression has been described as a successful alternative to surgical resection of the obstructing membrane. Our review of the literature revealed no reported cases utilizing radiofrequency (RF) energy to perforate the CTS membrane prior to balloon decompression. This manuscript describes two patients with CTS who were treated successfully with a transcatheter technique using RF energy to perforate the obstructing membrane prior to balloon angioplasty and decompression of the LA.
Intracardiac echocardiography for guidance of transcatheter left atrial appendage occlusion: An expert consensus document
Sergio Berti MD,Luigi E. Pastormerlo MD, PhD,Kasper Korsholm MD,Jacqueline Saw MD,Mohamad Alkhouli MD,Marco P. Costa MD,Jacob Odenstedt MD, PhD,Erik JS Packer MD,Claudio Tondo MD, PhD,Gennaro Santoro MD,Jens E. Nielsen-Kudsk MD, DMSc
doi : 10.1002/ccd.29791
Volume 98, Issue 4 p. 815-825
Transcatheter left atrial appendage occlusion (LAAO) is an increasingly used alternative to oral anticoagulation in selected patients with atrial fibrillation. Intraprocedural imaging is a crucial for a successful intervention, with transesophageal echocardiography (TEE) as the current gold standard. Since some important limitations may affect TEE use, intracardiac echocardiography (ICE) is increasingly used as an alternative to TEE for guiding LAAO. The lack of a standardized imaging protocol has slowed the adoption of ICE into clinical practice. On the basis of current research and expert consensus, this paper provides a protocol for ICE support of left atrial appendage occlusion.
Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes
Anastasios Roumeliotis MD,Bimmer E. Claessen MD, PhD,Samantha Sartori PhD,Davide Cao MD,Hanbo Qiu,Anton Camaj MD, MS,Johny Nicolas MD,Rishi Chandiramani MD,Ridhima Goel MD,Mauro Chiarito MD,Rebecca Torguson MPH,Joseph Sweeny MD,Nitin Barman MD,Prakash Krishnan MD,Annapoorna Kini MD,Samin K Sharma MD,George Dangas MD, PhD,Roxana Mehran MD
doi : 10.1002/ccd.29754
Volume 98, Issue 4 p. E494-E500
Women with acute coronary syndrome (ACS) generally present with more comorbidities and experience worse clinical outcomes compared with males. However, it is unclear whether this represents genuine sex-related difference or stems from clinical, procedural and socioeconomic factors.
Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention
Brian P O'Neill MD,Cindy Grines MD,Jeffrey W. Moses MD,E. Magnus Ohman MD,Alexandra Lansky MD,Jeffery Popma MD,Navin K. Kapur MD,Theodore Schreiber MD,Salvatore Mannino MD,William W. O'Neill MD,Amin M. Medjamia MD,Ehtisham Mahmud MD
doi : 10.1002/ccd.29758
Volume 98, Issue 4 p. E501-E512
To compare in-hospital outcomes of bailout support to prophylactic support with percutaneous ventricular assist devices (pVAD) for high-risk nonemergent percutaneous coronary intervention (HRPCI).
External validation of the GRACE risk score 2.0 in the contemporary all-comers GLOBAL LEADERS trial
Masafumi Ono MD,Hideyuki Kawashima MD,Hironori Hara MD,Amr Gamal MD, MRCP,Rutao Wang MD,Chao Gao MD,Neil O'Leary PhD,Osama Soliman MD, PhD,Jan J. Piek MD, PhD,Robert-Jan van Geuns MD, PhD,Peter Jüni MD,Christian W. Hamm MD,Marco Valgimigli MD, PhD,Pascal Vranckx MD, PhD,Stephan Windecker MD,Philippe Gabriel Steg MD,Keith AA Fox MB, ChB,Yoshinobu Onuma MD, PhD,Patrick W. Serruys MD, PhD
doi : 10.1002/ccd.29772
Volume 98, Issue 4 p. E513-E522
This study aimed to assess the predictive ability of the Global Registry of Acute Coronary Events (GRACE) risk score 2.0 in contemporary acute coronary syndrome (ACS) patients, and its relation to antiplatelet strategies.
The radioprotective effect of the Cathpax® AIR cabin during interventional cardiology procedures
Alejandro Gutierrez-Barrios MD, PhD,Esther Angulo-Pain MD,Inmaculada Noval-Morillas MD,Dolores Cañadas-Pruaño MD,Inara Alarcon de la Lastra MD,Livia Gheorghe MD,Ricardo Zayas-Rueda MD,German Calle-Perez MD,Rafael Vázquez-García MD, PhD
doi : 10.1002/ccd.29773
Volume 98, Issue 4 p. E523-E530
The use of ionizing radiation during cardiac catheterization interventions adversely impacts the medical staff. Traditional radiation protection equipment is only partially effective. The Cathpax® radiation protection cabin (RPC) has proven to significantly reduce radiation exposure in electrophysiological and neuroradiology interventions. Our objective was to analyze whether the Cathpax® RPC reduces radiation dose in coronary and cardiac structural interventions in unselected real-world procedures.
The DISCO study—Does Interventionalists' Sex impact Coronary Outcomes?
Prasanthi Yelavarthy MD,Milan Seth MS,Elizabeth Pielsticker MD,Cindy L. Grines MD,Claire S. Duvernoy MD,Devraj Sukul MD,Hitinder S. Gurm MBBS
doi : 10.1002/ccd.29774
Volume 98, Issue 4 p. E531-E539
To examine the association of operator sex with appropriateness and outcomes of percutaneous coronary intervention (PCI).
Feasibility of intravascular lithotripsy for calcific coronary lesions: A multi-institutional experience
Sylwia Iwa?czyk MD,Adrian W?odarczak MD,Jaros?aw Hiczkiewicz MD, PhD,Wojciech Faron MD,Marek Grygier MD, PhD,?ukasz Furtan MD,Magdalena ?anocha MD,Artur Jastrz?bski MD,Andrzej Siniawski MD,Maciej Lesiak MD, PhD
doi : 10.1002/ccd.29792
Volume 98, Issue 4 p. E540-E547
We sought to determine the safety and performance of intravascular lithotripsy in the treatment of severe calcified atherosclerotic lesions.
Safety and usefulness of a novel short track sliding balloon catheter
Young Hak Chung MD,Jung-Sun Kim MD, PhD,Sung-Yun Lee MD, PhD,Eui Im MD,Jong-Kwan Park MD,Sanghoon Shin MD,Jun-Won Lee MD, PhD,Seung Jun Lee MD, PhD,Sung-Jin Hong MD, PhD,Chul-Min Ahn MD, PhD,Byeong-Keuk Kim MD, PhD,Young-Guk Ko MD, PhD,Donghoon Choi MD, PhD,Myeong-Ki Hong MD, PhD,Yangsoo Jang MD, PhD
doi : 10.1002/ccd.29826
Volume 98, Issue 4 p. E548-E554
To evaluate the safety and technical utility of the short track sliding (STS) balloon catheter.
Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German-Austrian ABSORB RegIstRy
Niklas F. Boeder MD,Johannes Kastner MD,Julinda Mehilli MD,Thomas Münzel MD,Christoph Naber MD,Till Neumann MD,Gert Richardt MD,Axel Schmermund MD,Jochen Wöhrle MD,Ralf Zahn MD,Thomas Riemer,Stephan Achenbach MD,Christian W. Hamm MD,Holger M. Nef MD,for the GABI-R Study Group
doi : 10.1002/ccd.29829
Volume 98, Issue 4 p. E555-E563
We aimed to investigate predictors of scaffold failure and the potential impact of an optimized scaffold implantation technique by means of a learning curve on long-term clinical outcome after bioresorbable scaffold (BRS) implantation and to evaluate predictors of scaffold failure.
Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry
Monique Tröbs MD,Stephan Achenbach MD,Holger M. Nef MD,Tomasso Gori MD,Christoph Naber MD,Till Neumann MD, PhD,Gert Richardt MD,Axel Schmermund MD,Jochen Wöhrle MD,Ralf Zahn MD, MD,Christian W. Hamm MD,for the GABI-R Study Group
doi : 10.1002/ccd.29831
Volume 98, Issue 4 p. E564-E570
To identify potential differences in 2-year outcome between patients who underwent coronary revascularization using bioresorbable vascular scafffolds (BVS) in stable coronary artery disease (CAD) and acute coronary syndromes (ACS).
Predictors of prolonged guidewire manipulation time for native coronary chronic total occlusion percutaneous coronary intervention via primary antegrade approach
Yusuke Ochiumi MD,Masanori Yamamoto MD, PhD,Etsuo Tsuchikane MD, PhD,Toshiya Muramatsu MD,Koichi Kishi MD,Hisayuki Okada MD, PhD,Yuji Oikawa MD,Makoto Muto MD,Tomohiro Kawasaki MD,Ryohei Yoshikawa MD,Toshiaki Otsuka MD
doi : 10.1002/ccd.29844
Volume 98, Issue 4 p. E571-E580
This study aimed to identify the predictive factors for the guidewire manipulation time (GWMT) of ?20 and 30?min for chronic total occlusion-percutaneous coronary intervention (CTO-PCI) via the primary antegrade approach (PAA).
Improvement of symptoms and coronary perfusion gradient with mechanical left ventricular unloading in flow-limiting complex spontaneous coronary artery dissection, without revascularization
Giuseppe Tarantini MD, PhD,Tommaso Fabris MD,Giulio Rodinò MD,Chiara Fraccaro MD, PhD
doi : 10.1002/ccd.29836
Volume 98, Issue 4 p. E581-E585
Spontaneous coronary artery dissection (SCAD) can lead to acute coronary syndrome and sudden cardiac death, particularly in young women. Observational data show that, in SCAD patients, both percutaneous coronary intervention and coronary artery bypass grafting seem to be hampered by higher technical complexity, lower success rates, and worse outcomes. As spontaneous healing is a common occurrence, expert consensus advices medical management of the acute phase, when feasible. We present the case of a young woman with SCAD of left anterior descending artery causing myocardial infarction with ST-segment elevation. High-anatomical complexity and unstable conditions of the patient made both medical management and immediate revascularization unfeasible options. Therefore, we decided to implant a percutaneous off-loading mechanical support device to improve coronary perfusion pressure by unloading the left ventricle and preserve cardiac function, preventing worse complications of acute myocardial infarction. This strategy was successful in stabilizing the patient, until the definitive revascularization treatment became an option.
In-hospital outcomes of endovascular versus surgical revascularization for chronic total occlusion in peripheral artery disease
Mohamed Zghouzi MD,Homam Moussa Pacha MD,Waqas Ullah MD,Yasar Sattar MD,Bachar Ahmad BS,Heba Osman MD,Mohamed O. Mohamed MRCP(UK),Tanveer Mir MD
doi : 10.1002/ccd.29827
Volume 98, Issue 4 p. E586-E593
The outcome of endovascular intervention (EVI) compared vs. surgical revascularization in patients with peripheral artery disease (PAD) due to chronic total occlusion (CTO) is unknown.
QRS duration is a risk indicator of adverse outcomes after MitraClip
Atsushi Sugiura MD PhD,Marcel Weber MD,Noriaki Tabata MD PhD,Tadahiro Goto MD MPH PhD,Can Öztürk MD,Maoshin Lin MD,Sebastian Zimmer MD,Georg Nickenig MD,Jan-Malte Sinning MD
doi : 10.1002/ccd.29505
Volume 98, Issue 4 p. E594-E601
While QRS duration is a known marker of left ventricular (LV) function, little is known about its utility for predicting clinical prognosis after transcatheter mitral valve repair (TMVR). We investigated the association between QRS duration and one-year adverse events after TMVR with the MitraClip system.
Temporal outcomes of transcatheter mitral valve replacement in native mitral valve disease with annular calcification
Mohammed A. Al-Hijji MD,Stephanie ElHajj MD,Abdallah El Sabbagh MD,Mohamad A. Alkhouli MD,Juan Crestanello MD,Mackram F. Eleid MD,Charanjit Rihal MD, MBA,Mayra Guerrero MD
doi : 10.1002/ccd.29515
Volume 98, Issue 4 p. E602-E609
Surgical intervention in patients with native mitral disease due to severe mitral annular calcification (MAC) carries significant risk. Transcatheter mitral valve replacement (TMVR) using balloon-expandable aortic transcatheter heart valve (THV) in MAC had emerged as alternative treatment.
A new over-the-wire percutaneous mitral balloon valvuloplasty technique
Hellmuth Weich MD,Lize-Mari van Veyeren MD
doi : 10.1002/ccd.29664
Volume 98, Issue 4 p. E610-E616
To develop and evaluate a new over-the-wire technique for mitral valvuloplasty that is both technically easier and less costly.
Percutaneous mitral valve repair with MitraClip device in hemodynamically unstable patients: A systematic review
Eduardo Martinez-Gomez MD,Angela McInerney MD,Gabriela Tirado-Conte MD,Jose Alberto de Agustin MD, PhD,Pilar Jimenez-Quevedo MD, PhD,Andrés Escudero MD,Eduardo Pozo Osinalde MD, PhD,Ana Viana-Tejedor MD, PhD,Josebe Goirigolzarri MD, PhD,Luis Marroquin MD,David Vivas MD, PhD,Carlos Ferrera MD, PhD,Francisco Noriega MD, PhD,Maria Alejandra Restrepo-Cordoba MD,Nieves Gonzalo MD, PhD,Javier Escaned MD, PhD,Antonio Fernández-Ortiz MD, PhD,Ignacio Amat-Santos MD, PhD,Rodrigo Estevez-Loureiro MD, PhD,Carlos Macaya MD, PhD,Luis Nombela-Franco MD, PhD
doi : 10.1002/ccd.29703
Volume 98, Issue 4 p. E617-E625
Very few data exist on percutaneous mitral valve repair (PMVr) in unstable patients with concomitant moderate–severe mitral regurgitation (MR). The purpose of this systematic review was to evaluate baseline characteristics, management and clinical outcomes of critically ill patients undergoing PMVr with MitraClip.
Initial experience with the fourth generation MitraClip™: Outcomes, procedural aspects, and considerations for device selection
Enrique Garcia-Sayan MD,Deepa Raghunathan MD,Flora M. Li MD,Abhijeet Dhoble MD, MPH,Richard D. Sheu MD,Srdjan Jelacic MD,Mark Reisman MD,Richard W. Smalling MD, PhD,G. Burkhard Mackensen MD, PhD
doi : 10.1002/ccd.29705
Volume 98, Issue 4 p. E626-E636
We present our initial experience with the fourth-generation MitraClip™ (G4) system and propose preliminary criteria for device selection.
Early outcomes from the CLASP IID trial roll-in cohort for prohibitive risk patients with degenerative mitral regurgitation
D. Scott Lim MD,Robert L. Smith MD,Firas Zahr MD,Abhijeet Dhoble MD,Roger Laham MD,Mohamad Lazkani MD,Susheel Kodali MD,Chad Kliger MD,James Hermiller MD,Amit Vora MD,Ian J. Sarembock MB, ChB, MD,William Gray MD,Samir Kapadia MD,Adam Greenbaum MD,Andrew Rassi MD,David Lee MD,Adnan Chhatriwalla MD,Pinak Shah MD,Josep Rodés-Cabau MD,Homam Ibrahim MD,Lowell Satler MD,Howard C. Herrmann MD,Paul Mahoney MD,Charles Davidson MD,George Petrossian MD,Mayra Guerrero MD,Konstantinos Koulogiannis MD,Leo Marcoff MD,Linda Gillam MD,The CLASP IID Pivotal Trial Investigators
doi : 10.1002/ccd.29749
Volume 98, Issue 4 p. E637-E646
We report the 30-day outcomes from the roll-in cohort of the CLASP IID trial, representing the first procedures performed by each site.
